Search
Returning search results with filters:
Remove filter for
Audience: Industry
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2024
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 16 - 30 of 40 items.
Miracle Reds: missing risk statement
RecallHealth product recall | 2024-04-23
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
I-131 Diagnostic Capsule: Affected lots may have decreased thyroid uptake.
RecallHealth product recall | 2024-04-17
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
Honeywell Eyesaline Emergency Eyewash: deficiencies in Good Manufacturing Practices (GMP)
RecallHealth product recall | 2024-04-04
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02
Health Canada warns against using certain henna cone products that can cause chemical burns to skin
AlertPublic advisory | 2024-03-28
Viatrexx Ki-Diab: Incorrect medicinal ingredient
RecallHealth product recall | 2024-03-25
JAMP CEPHALEXIN SUSPENSION: Suspendability out of specification
RecallHealth product recall | 2024-03-21
Equate Vitamin D Droplets Kids: incorrect outer carton
RecallHealth product recall | 2024-03-18
FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.
RecallHealth product recall | 2024-03-12
Nutracelle Nutramin Vitamin for Kids : Affected lot contains Vitamin B6 and Folate levels outside of the labelled claim.
RecallHealth product recall | 2024-02-20
PDP-Desonide : Tubes may leak, in the affected lot.
RecallHealth product recall | 2024-02-20
APO-MOMETASONE : Affected lots may contain the presence of bacterial contamination.
RecallHealth product recall | 2024-02-19